|Bid||104.20 x 1000|
|Ask||104.27 x 1000|
|Day's Range||102.93 - 106.04|
|52 Week Range||58.46 - 119.60|
|Beta (5Y Monthly)||1.00|
|PE Ratio (TTM)||71.01|
|Earnings Date||Feb 13, 2023 - Feb 17, 2023|
|Forward Dividend & Yield||1.60 (1.50%)|
|Ex-Dividend Date||Nov 14, 2022|
|1y Target Est||116.21|
CF (CF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
A biotechnology company accused Citadel Securities LLC, Susquehanna International Group LLP and other Wall Street firms of driving down its stock price through a series of illicit trading tactics. In a lawsuit filed Thursday in Manhattan federal court, Northwest Biotherapeutics alleged the market makers had repeatedly engaged in “spoofing,“ where traders place orders with an intent to fool other investors about a stock’s demand and manipulate the price.
CF (CF) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.